Organogenesis Holdings Inc. (ORGO) Insider Trading Disclosures
Organogenesis Holdings Inc. (ORGO) is a publicly traded company on the Nasdaq, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: ORGO
CIK: 1661181
Exchange: Nasdaq
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
RSM US LLP
Auditor SinceSince 12/31/2018 12:00:00 AM
Lead Engagement PartnerMeaghan Switzer
Audit LocationBoston, Massachusetts, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 8-K | 2026-08-06 | 2026-08-06 | 8-K | 0001193125-26-338321 | View SEC Doc Filr Page |
| 424B5 | 2026-08-06 | — | 424B5 | 0001193125-26-338296 | View SEC Doc Filr Page |
| 10-Q | 2026-08-06 | 2026-06-30 | 10-Q | 0001193125-26-338049 | View SEC Doc Filr Page |
| 8-K | 2026-08-06 | 2026-08-06 | 8-K | 0001193125-26-338022 | View SEC Doc Filr Page |
| 8-K | 2026-06-16 | 2026-06-15 | 8-K | 0001193125-26-272710 | View SEC Doc Filr Page |
| 10-Q | 2026-05-07 | 2026-03-31 | 10-Q | 0001661181-26-000008 | View SEC Doc Filr Page |
| 8-K | 2026-05-07 | 2026-05-07 | 8-K | 0001661181-26-000007 | View SEC Doc Filr Page |
| ARS | 2026-04-30 | 2025-12-31 | ARS | 0001193125-26-197380 | View SEC Doc Filr Page |
| DEF 14A | 2026-04-30 | 2026-06-15 | DEF 14A | 0001193125-26-197357 | View SEC Doc Filr Page |
| 4 | 2026-04-24 | 2025-01-10 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 0002064832-26-000183 | View SEC Doc Filr Page |
| 4 | 2026-03-11 | 2026-03-09 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 0002064832-26-000129 | View SEC Doc Filr Page |
| 4 | 2026-03-11 | 2026-03-09 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 0002064832-26-000127 | View SEC Doc Filr Page |
| 4 | 2026-03-03 | 2026-03-01 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 0002064832-26-000093 | View SEC Doc Filr Page |
| 4/A | 2026-03-03 | 2026-02-18 | AMENDED STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 0002064832-26-000092 | View SEC Doc Filr Page |
| 4/A | 2026-03-03 | 2026-02-18 | AMENDED STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 0002064832-26-000091 | View SEC Doc Filr Page |
| 4/A | 2026-03-03 | 2026-02-18 | AMENDED STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 0002064832-26-000090 | View SEC Doc Filr Page |
| 4/A | 2026-03-03 | 2026-02-18 | AMENDED STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 0002064832-26-000089 | View SEC Doc Filr Page |
| 4/A | 2026-03-03 | 2026-02-18 | AMENDED STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 0002064832-26-000088 | View SEC Doc Filr Page |
| 4/A | 2026-03-03 | 2026-02-18 | AMENDED STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 0002064832-26-000087 | View SEC Doc Filr Page |
| 4/A | 2026-03-03 | 2026-02-18 | AMENDED STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 0002064832-26-000086 | View SEC Doc Filr Page |
| 3 | 2026-02-27 | 2026-02-18 | INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES | 0002064832-26-000065 | View SEC Doc Filr Page |
| 10-K | 2026-02-26 | 2025-12-31 | 10-K | 0001193125-26-076730 | View SEC Doc Filr Page |
| 8-K | 2026-02-26 | 2026-02-26 | 8-K | 0001193125-26-076595 | View SEC Doc Filr Page |
| 8-K | 2026-02-23 | 2026-02-18 | 8-K | 0001193125-26-064270 | View SEC Doc Filr Page |
| 4 | 2026-02-20 | 2026-02-18 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 0002064832-26-000062 | View SEC Doc Filr Page |